Landscape Capital Management, L.L.C. Apellis Pharmaceuticals, Inc. Transaction History
Landscape Capital Management, L.L.C.
- $835 Million
- Q4 2024
A detailed history of Landscape Capital Management, L.L.C. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Landscape Capital Management, L.L.C. holds 49,986 shares of APLS stock, worth $1.3 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
49,986
Previous 26,900
85.82%
Holding current value
$1.3 Million
Previous $775,000
105.81%
% of portfolio
0.19%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$318 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$309 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$307 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$261 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$250 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.86B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...